What are the implications of the SAMHSA final rule to increase the Buprenorphine patient limit to 275?

Buprenorphine prescribing limits are often cited as a factor limiting access to treatment for opioid use disorders. Licensed physicians who have had a waiver to treat 100 patients for at least 1 year can become eligible for the patient limit of 275. Eligible practitioners who want to increase their patient limit to 275 must adhere to nationally recognized evidence-based guidelines for treating patients with opioid use disorder, adhere to a diversion control plan to reduce the possibility of diversion of buprenorphine, provide patients with necessary behavioral health services either directly or through a formal agreement with another entity and use patient data to inform improvement of outcomes.

Access “Understanding the Final Rule for a Patient Limit of 275” at: https://pcssnow.org/resource/understanding-final-rule-patient-limit-275/

More information can be found at: https://www.samhsa.gov/medication-assisted-treatment/training-materials-resources/buprenorphine-waiver

  • Was this Helpful ?
  • YesNo

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.